Ceftriaxone and Hypothermia - a phase IV clinical study of FDA data
Summary:
Hypothermia is reported as a side effect among people who take Ceftriaxone (ceftriaxone sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Pneumonia.
The phase IV clinical study analyzes which people have Hypothermia when taking Ceftriaxone. It is created by eHealthMe based on reports of 40,872 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly.
What is Ceftriaxone?
Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.
What is Hypothermia?
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions) is found to be associated with 776 drugs and 997 conditions by eHealthMe. Check the latest studies of Hypothermia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
40,872 people reported to have side effects when taking Ceftriaxone.
Among them, 52 people (0.13%) have Hypothermia.

Among these 52 people:
How long have people been on Ceftriaxone when they have Hypothermia? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hypothermia when taking Ceftriaxone? *
- female: 55.1 %
- male: 44.9 %
What is the age of people who have Hypothermia when taking Ceftriaxone? *
- 0-1: 6.52 %
- 2-9: 15.22 %
- 10-19: 0.0 %
- 20-29: 4.35 %
- 30-39: 15.22 %
- 40-49: 6.52 %
- 50-59: 23.91 %
- 60+: 28.26 %
What are other drugs people take besides Ceftriaxone? *
- Pantoprazole: 11 people, 21.15%
- Vancomycin: 8 people, 15.38%
- Morphine: 5 people, 9.62%
- Digoxin: 4 people, 7.69%
- Ondansetron: 4 people, 7.69%
- Acetaminophen: 3 people, 5.77%
- Spironolactone: 3 people, 5.77%
- Bupivacaine: 3 people, 5.77%
- Dexamethasone: 3 people, 5.77%
- Heparin: 3 people, 5.77%
What are other side effects people have besides Hypothermia? *
- Hypoglycemia (low blood sugar): 11 people, 21.15%
- Hypotension (abnormally low blood pressure): 11 people, 21.15%
- Cardiogenic Shock (inadequate circulation of blood): 9 people, 17.31%
- Bradycardia (abnormally slow heart action): 9 people, 17.31%
- Urinary Retention (the inability to completely or partially empty the bladder): 8 people, 15.38%
- Toxic Shock Syndrome (a rare but serious medical condition caused by a bacterial infection): 7 people, 13.46%
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 7.69%
- Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 3 people, 5.77%
- Hyperhidrosis (abnormally increased sweating): 3 people, 5.77%
- Consciousness - Decreased: 3 people, 5.77%
What are the existing conditions these people have? *
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 7.69%
- Pneumonia: 4 people, 7.69%
- Respiratory Tract Infection: 3 people, 5.77%
- Pulmonary Haemorrhage (acute bleeding from the lung): 3 people, 5.77%
- Fever: 3 people, 5.77%
- Febrile Neutropenia (fever with reduced white blood cells): 3 people, 5.77%
- Urinary Tract Infection: 2 people, 3.85%
- Thrombocytopenia (decrease of platelets in blood): 2 people, 3.85%
- Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 2 people, 3.85%
- Cough: 2 people, 3.85%
* Approximation only. Some reports may have incomplete information.
Do you take Ceftriaxone and have Hypothermia?
- Check whether Hypothermia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone:
- Ceftriaxone (40,991 reports)
Hypothermia treatments and more:
- Hypothermia (12,298 reports)
How severe was Hypothermia and when was it recovered:
Expand to all the drugs that have ingredients of ceftriaxone sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ceftriaxone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypothermia:
- Hypothermia (776 drugs)
Browse all the conditions that are associated with Hypothermia:
- Hypothermia (997 conditions)
Related publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Losartan and Communication Disorder for Women aged 60+ - 5 seconds ago
- Suicide Attempt and Metabolic Disorder - 20 seconds ago
- Etomidate and Potassium drug interactions for men aged 60+ - 22 seconds ago
- Melatonin and Myasthenia Gravis for Men aged 60+ - 26 seconds ago
- Appetite - Increased and drugs of ingredients of acetaminophen; codeine phosphate - 29 seconds ago
- Drug interactions of Fluconazole and Excedrin - 29 seconds ago
- Prednisone and Norditropin drug interactions for girls aged 10-19 - 34 seconds ago
- Drug interactions of Pioglitazone Hydrochloride and Tamsulosin - 38 seconds ago
- Promacta and Vitamin D drug interactions for women aged 50-59 - 40 seconds ago
- Could Norvir cause Coordination Abnormal? - 44 seconds ago